New and updated preclinical data presented at the American Society of Hematology Annual Meeting in New Orleans, by: Ajax Therapeutics, Biomea Fusion, Cimeio Therapeutics, Fate Therapeutics, Graphite Bio, GT Biopharma, Ichnos Sciences, IGM Biosciences, Incyte, Kronos Bio, Kymera Therapeutics, Monopar Therapeutics, Orum Therapeutics, OSE Immunotherapeutics, Poseida Therapeutics, Puretech Health, Schrödinger, Senti Biosciences, Vincerx Pharma, Wugen.